O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.39%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$10.3B
AUM Growth
+$10.3B
(+13%)
Cap. Flow
+$348M
Cap. Flow
% of AUM
3.38%
Top 10 Holdings %
Top 10 Hldgs %
36.86%
Holding
137
New
10
Increased
53
Reduced
17
Closed
11
Top Buys
| 1 |
Biogen
BIIB
|
$103M |
| 2 |
SIEN
Sientra, Inc.
SIEN
|
$53.5M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$49.5M |
| 4 |
MGLN
Magellan Health Services, Inc.
MGLN
|
$48.3M |
| 5 |
Gilead Sciences
GILD
|
$45.9M |
Top Sells
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
$215M |
| 2 |
Arrowhead Research
ARWR
|
$76.5M |
| 3 |
STJ
St Jude Medical
STJ
|
$55.3M |
| 4 |
QGENF
QIAGEN NV
QGENF
|
$38.7M |
| 5 |
OraSure Technologies
OSUR
|
$34.4M |
Sector Composition
| 1 | Healthcare | 87.22% |
| 2 | Financials | 0.08% |
| 3 | Technology | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$210B
| $166M | 1.58% | 2,915,300 +253,300 | +10% | +$14.4M |
|
27
Regeneron Pharmaceuticals
REGN
$61.5B
| $160M | 1.53% | 390,200 +20,600 | +6% | +$8.45M |
|
|
AGN
28
DELISTED
ALLERGAN INC
AGN
| $158M | 1.51% | 741,300 -156,400 | -17% | -$33.2M |
|
29
McKesson
MCK
$85.4B
| $154M | 1.47% | 742,000 +34,000 | +5% | +$7.06M |
|
30
Zimmer Biomet
ZBH
$21B
| $145M | 1.39% | 1,282,700 +23,000 | +2% | +$2.61M |
|
31
Neurocrine Biosciences
NBIX
$13.8B
| $133M | 1.27% | 5,968,600 +175,000 | +3% | +$3.91M |
|
|
TRNX
32
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $123M | 1.17% | 4,805,000 | – | – |
|
|
NPSP
33
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $106M | 1.01% | 2,954,900 +338,900 | +13% | +$12.1M |
|
34
Stryker
SYK
$150B
| $97.3M | 0.93% | 1,031,600 +29,000 | +3% | +$2.74M |
|
35
Insulet
PODD
$23.9B
| $92M | 0.88% | 1,997,000 +44,000 | +2% | +$2.03M |
|
36
Pfizer
PFE
$141B
| $85.9M | 0.82% | 2,759,000 +89,000 | +3% | +$2.77M |
|
|
INFI
37
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $80M | 0.76% | 4,736,900 | – | – |
|
|
OTIC
38
DELISTED
Otonomy, Inc.
OTIC
| $75.2M | 0.72% | 2,256,398 | – | – |
|
|
MGLN
39
DELISTED
Magellan Health Services, Inc.
MGLN
| $72.5M | 0.69% | 1,208,000 +805,400 | +200% | +$48.3M |
|
40
Standard BioTools
LAB
$481M
| $72.1M | 0.69% | 2,136,200 +36,000 | +2% | +$1.21M |
|
|
WMGI
41
DELISTED
Wright Medical Group Inc
WMGI
| $67.9M | 0.65% | 2,527,000 +83,000 | +3% | +$2.23M |
|
|
AFFX
42
DELISTED
AFFYMETRIX INC
AFFX
| $64.8M | 0.62% | 6,568,000 | – | – |
|
|
ALXN
43
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $61.4M | 0.59% | 332,000 +20,000 | +6% | +$3.7M |
|
|
MNK
44
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $56.2M | 0.54% | 567,001 +273,000 | +93% | +$27M |
|
|
SIEN
45
DELISTED
Sientra, Inc.
SIEN
| $53.5M | 0.51% | +3,185,308 | New | +$53.5M |
|
|
INSY
46
DELISTED
Insys Therapeutics, Inc.
INSY
| $52.4M | 0.5% | 1,243,200 +507,600 | +69% | +$21.4M |
|
47
Johnson & Johnson
JNJ
$427B
| $51.8M | 0.49% | 495,000 +72,000 | +17% | +$7.53M |
|
|
NUVA
48
DELISTED
NuVasive, Inc.
NUVA
| $50.6M | 0.48% | 1,072,000 +410,000 | +62% | +$19.3M |
|
|
TSRO
49
DELISTED
TESARO, Inc.
TSRO
| $49.5M | 0.47% | +1,330,000 | New | +$49.5M |
|
50
Exact Sciences
EXAS
$8.98B
| $48.8M | 0.47% | 1,778,000 +55,000 | +3% | +$1.51M |
|